Dolutegravir
Spécifications
1051375-16-6Numéro CAS
809-888-1Numéro CE
(3S,7R)-N-[(2,4-difluorophenyl)methyl]-11-hydroxy-7-methyl-9,12-dioxo-4-oxa-1,8-diazatricyclo[8.4.0.03,8]tetradeca-10,13-diene-13-carboxamideNom IUPAC
C20H19F2N3O5Formule chimique
419.4 g/molMasse molaire
Dolutegravir; 1051375-16-6; GSK1349572; S/GSK1349572; GSK 1349572; GSK-1349572; S-349572; (4R,12aS)-N-[(2,4-Difluorophenyl)methyl]-3,4,6,8,12,12a-hexahydro-7-hydroxy-4-methyl-6,8-dioxo-2H-pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxamide; DKO1W9H7M1; CHEBI:76010; DTXSID90909356; 2H-Pyrido(1',2':4,5)pyrazino(2,1-b)(1,3)oxazine-9-carboxamide, N-((2,4-difluorophenyl)methyl)-3,4,6,8,12,12a-hexahydro-7-hydroxy-4-methyl-6,8-dioxo-, (4R,12aS)-; dolutegravirum; (4R,12aS)-N-((2,4-difluorophenyl)methyl)-3,4,6,8,12,12a-hexahydro-7-hydroxy-4-methyl-6,8-dioxo-2H-Pyrido(1',2':4,5)pyrazino(2,1-b)(1,3)oxazine-9-carboxamide; (4R,12aS)-N-((2,4-difluorophenyl)methyl)-7-hydroxy-4-methyl-6,8-dioxo-3,4,12,12a-tetrahydro-2H-pyrido(5,6)pyrazino(2,6-b)(1,3)oxazine-9-carboxamide; (4R,12aS)-N-[(2,4-difluorophenyl)methyl]-7-hydroxy-4-methyl-6,8-dioxo-3,4,12,12a-tetrahydro-2H-pyrido[5,6]pyrazino[2,6-b][1,3]oxazine-9-carboxamide; RefChem:56964; J05AX12; DTXCID701338419; (14C)-(4R,12aS)-N-(2,4-difluorobenzyl)-7-hydroxy-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-(1,3)oxazino(3,2-a)pyrido(1,2-d)pyrazine-9-carboxamide; (4R,9aS)-5-hydroxy-4-methyl-6,10-dioxo-3,4,6,9,9a,10-hexahydro-2H-1-oxa-4a,8a-diaza-anthracene-7-carboxylic acid-2,4 difluorobenzylamide; 2H-Pyrido(1',2':4,5)pyrazino(2,1-b)(1,3)oxazine-9-carboxamide, N-((2,4-difluorophenyl)methyl)-3,4,6,8,12,12a-hexahydro-7-hydroxy-4-methyl-6,8-dioxo-, (4R,12aS); Tivicay; Dolutegravir (GSK1349572); (4r,12as)-N-(2,4-Difluorobenzyl)-7-Hydroxy-4-Methyl-6,8-Dioxo-3,4,6,8,12,12a-Hexahydro-2h-Pyrido[1',2':4,5]pyrazino[2,1-B][1,3]oxazine-9-Carboxamide; Dolutegravir DTG; Dolutegravir [USAN]; (3S,7R)-N-[(2,4-difluorophenyl)methyl]-11-hydroxy-7-methyl-9,12-dioxo-4-oxa-1,8-diazatricyclo[8.4.0.03,8]tetradeca-10,13-diene-13-carboxamide; Dolutegravir (USAN); GSK1349572A; Tivicay (TN); Dolutegravir (0.1 mg/mL in Methanol); Dolutegravir [USAN:INN]; UNII-DKO1W9H7M1; Soltegravir; Dolutegravir?; HSDB 8152; C20H19F2N3O5; MFCD20488027; S-GSK1349572; 1051375-16-6 (free); 3s3m; 3s3n; 3s3o; Dolutegravir (Standard); (4R,12aS)-N-[(2,4-difluorophenyl)methyl]-7-hydroxy-4-methyl-6,8-dioxo-3,4,12,12a-tetrahydro-2H-pyrido[[?]:[?]]pyrazino[[?]][1,3]oxazine-9-carboxamide; DOLUTEGRAVIR [MI]; DOLUTEGRAVIR [INN]; DOLUTEGRAVIR [VANDF]; SCHEMBL82071; MLS006011137; DOLUTEGRAVIR [WHO-DD]; GTPL7365; orb1300988; orb3141325; CHEMBL1229211; SCHEMBL15397915; SCHEMBL29357473; RHWKPHLQXYSBKR-BMIGLBTASA-N; GLXC-90267; EX-A1695; BDBM50062551; EBC-27030; HY-13238R; s2667; AKOS025396657; S/GSK-1349572; CCG-268876; CS-0454; DB08930; FD43372; NCGC00346629-01; NCGC00346629-02; NCGC00346629-06; NCGC00346629-11; (3S,7R)-N-[(2,4-difluorophenyl)methyl]-11-hydroxy-7-methyl-9,12-dioxo-4-oxa-1,8-diazatricyclo[8.4.0.0^{3,8}]tetradeca-10,13-diene-13-carboxamide; AC-28371; AS-75277; HY-13238; SMR004702915; NS00099377; T6198; S/GSK1349572,GSK1349572; D10066; EN300-7409916; F799806; Q937224; Z2235801952; (3S,7R)-N-[(2,4-difluorophenyl)methyl]-11-hydroxy-7-methyl-9,12-dioxo-4-oxa-1,8-diazatricyclo[8.4.0.0(3),?]tetradeca-10,13-diene-13-carboxamide; (3S,7R)-N-[(2,4-difluorophenyl)methyl]-11-hydroxy-7-methyl-9,12-dioxo-4-oxa-1,8-diazatricyclo[8.4.0.0,3,8]tetradeca-10,13-diene-13-carboxamide; (4R,12.ALPHA.S)-N-((2,4-DIFLUOROPHENYL)METHYL)-7-HYDROXY-4-METHYL-6,8-DIOXO-3,4,6,8,12,12.ALPHA.-HEXAHYDRO-2H-PYRIDO(1',2':4,5)PYRAZINO(2,1-.BETA.)(1,3)OXAZINE-9-CARBOXAMIDE; (4R,12aS)-N-(2,4-difluorobenzyl)-7-hydroxy-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-[1,3]oxazino[3,2-a]pyrido[1,2-d]pyrazine-9-carboxamide; (4R,12aS)-N-(2,4-Difluorobenzyl)-7-hydroxy-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-[1,3]oxazino[3,2-d]pyrido[1,2-a]pyrazine-9-carboxamide; (4R,12aS)-N-[(2,4-Difluorophenyl)methyl]-7-hydroxy-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxamideSynonymes
Produits contenant Dolutegravir
AcriptegaDolutegravir 50mg, Lamivudine 300mg & Tenofovir Disoproxil Fumarate 300mg TabletsDolatevirDolvir TLDHetegravir 50TRIPLEVIRGSK 1349572DOLUTEGRAVIRDolutegravirDolutegravirdolutegravirDolutegravir
Page 1 sur 2
Entreprises vendant Dolutegravir
MP
Macleods Pharmaceuticals LimitedIndiaHD
Hangzhou Dingyan Chem Co., LtdChinaZE
Zhejiang Eazy Pharmchem Co., Ltd.ChinaCS
China Synchem Technology Co., Ltd.ChinaWH
Wuxi Hexia Chemical CompanyChinaSR
Suzhou Ryway Biotech Co., LtdChinaMP
MI Pharma Private LimitedIndiaSH
Shenzhen Haorui Pharmatech Co., Ltd.ChinaPage 1 sur 2